Medication Safety Resources Archive

November 2: FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury

September 1: FDA Requests the Removal of Pregnancy as a Contraindication Against using Stains

June 16: Alcohol-Based Hand Sanitizers

July 19: FDA Requests the Removal of Pregnancy as a Contraindication Against using Stains

May 25: FDA Restricts Use of Obeticholic Acid (Ocaliva®) in Some Primary Biliary Cholangitis (PBC) Patients

March 25: Abuse and misuse of propylhexedrine nasal decongestant causes serious harm

February 4: Tofacitinib (Xeljanz®) may increase risk of serious heart-related problems and cancer

December 15: FDA Updates Emergency Use Authorization (EUA) for Janssen COVID-19 Vaccine:Addresses risks of Thrombosis with Thrombocytopenia Syndrome (TTS)

October 6: Seasonal Influenza Vaccine Safety: Reporting Adverse Vaccine Events to the Vaccine Adverse Event Reporting System (VAERS)

August 26: Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19

July 15: Revised Fact Sheets: FDA Warns of Increased Risk of Guillain-Barré Syndrome following Janssen COVID-19 Vaccination

June 28: Revised Fact Sheets: Myocarditis & Pericarditis Following mRNA COVID-19 Vaccination

May 28: Myocarditis & Pericarditis Following mRNA COVID-19 Vaccination

April 26: Pause Lifted on Johnson & Johnson COVID-19 Vaccine Use

April 15: Adverse Vaccine Events Potentially Associated with the Johnson & Johnson/Janssen COVID-19 Vaccine

January 6: One Vial of BAMLANIVIMAB Must Be Combined with Two Vials of ETESEVIMAB for Infusion

January 6: Vaccine Safety: Anaphylaxis and COVID-19 Vaccinations

December 14: V-Safe After-Vaccination Health Checker

October 15: NSAID Use During Pregnancy May Cause Fetal Renal Dysfunction

September 23: New Boxed Warning for Benzodiazepines

April 24: Adverse Drug Events: Hydroxychloroquine and Heart Rhythm

March 4: Montelukast and Risk of Mental Health Side Effects

February 13: FDA Requests Withdrawal of Lorcaserin

January 28: Risks Exist Between Clozapine and Serious Bowel Problems

November 10: Remdesivir (Veklury®) Prescribing Information Update

August 26: FDA Removes Boxed Warning About Risk of Leg and Foot Amputations for Canagliflozin (Invokana®)

July 23: FDA Recommends Discussing Naloxone with All Patients Receiving Opioid Prescriptions

July 2: Methanol-Containing Hand Sanitizers Can be Toxic

June 15: Hydroxychloroquine Emergency Use Authorization (EUA) for the treatment of COVID-19 Revoked

June 12: Metfomin Extended Release NMDA Recall

March 30: Unknown Risks with Unapproved COVID-19 Treatments

March 27: Prioritizing Vaccinations for Young Children During COVID-19

March 24: Severe Illness with Non-Pharmaceutical Chloroquine Phosphate

March 23: Use of NSAIDs for COVID-19

March 15: Hydroxychloroquine With and Without Azithromycin for COVID-19

December 14: Serious Breathing Difficulty Risk with Gabapentinoids

September 13: Warning Issued about Lung Inflammation with Ibrance, Kisqali, and Verzenio for Breast Cancer

August 28: Rare Occurrence of Serious Liver Disease in Some Patients with Use of Hepatitis C Medicines

August 13: No Increased Risk of Prostate Cancer Found with the Use of Entacapone to Treat Parkinson's Disease

July 26: Increased Risk of Blood Clots and Death with Tofacitinib (Xeljanz, Xeljanz XR)

December 10: Non-FDA Approved Treatments with Exosome Therapies May Result in Serious Adverse Drug Events

December 6: No Recalls of Metformin in U.S.

October 2: FDA Issues Recall of Ranitidine

September 15: Look Alike, Sound Alike (LASA) Medications

January 15: Statin-Associated Autoimmune Myopathy